GlobeNews Wire

GlobeNews Wire

Scorpius Holdings Announces Corporate Update Including Cost Optimization Initiatives, Strategic Corporate Developments, and Potential Opportunities for Expansion into Southeast AsiaScorpius Holdings Announces Corporate Update Including Cost Optimization Initiatives, Strategic Corporate Developments, and Potential Opportunities for Expansion into Southeast Asia

Scorpius Holdings Announces Corporate Update Including Cost Optimization Initiatives, Strategic Corporate Developments, and Potential Opportunities for Expansion into Southeast Asia

Operational Realignment Expected to Deliver Over $6 Million in Annual Cost Savings Company Exploring CDMO Expansion Opportunities in Southeast Asia…

8 hours ago
Preliminary Phase 1b/2 Data for REC-4881 in Familial Adenomatous Polyposis (FAP) Demonstrates Reduced Polyp BurdenPreliminary Phase 1b/2 Data for REC-4881 in Familial Adenomatous Polyposis (FAP) Demonstrates Reduced Polyp Burden

Preliminary Phase 1b/2 Data for REC-4881 in Familial Adenomatous Polyposis (FAP) Demonstrates Reduced Polyp Burden

In the Phase 2 open-label study, REC-4881 (4 mg QD) led to a median 43% reduction (n=6 patients) in polyp…

8 hours ago
New Data at DDW 2025 Further Demonstrates the TissueCypher Test’s Ability to Identify Patients at Increased Risk for Developing Esophageal CancerNew Data at DDW 2025 Further Demonstrates the TissueCypher Test’s Ability to Identify Patients at Increased Risk for Developing Esophageal Cancer

New Data at DDW 2025 Further Demonstrates the TissueCypher Test’s Ability to Identify Patients at Increased Risk for Developing Esophageal Cancer

Additionally, an expert physician panel convened by EndoscopyNow will host a product theater on Sunday, May 4, at 2:45 p.m.…

8 hours ago
Xilio Therapeutics Announces Inducement Grant UnderNasdaq Listing Rule 5635(c)(4)Xilio Therapeutics Announces Inducement Grant UnderNasdaq Listing Rule 5635(c)(4)

Xilio Therapeutics Announces Inducement Grant UnderNasdaq Listing Rule 5635(c)(4)

May 02, 2025 16:30 ET  | Source: Xilio Therapeutics, Inc. WALTHAM, Mass., May 02, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics,…

8 hours ago
Result of General MeetingResult of General Meeting

Result of General Meeting

May 2, 2025 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Result of General Meeting Biodexa Pharmaceuticals PLC, (Nasdaq: BDRX), a clinical…

8 hours ago
Bolys High Performance Concentrated Solar Products Move into Mass ProductionBolys High Performance Concentrated Solar Products Move into Mass Production

Bolys High Performance Concentrated Solar Products Move into Mass Production

MUNICH, May 03, 2025 (GLOBE NEWSWIRE) -- Boly Inc., a global high-tech company headquartered in Silicon Valley, is pleased to…

18 hours ago
How to Claim Your $750 Shein Gift Card Is It Legit or Fake? – UpLevelRewardsHow to Claim Your $750 Shein Gift Card Is It Legit or Fake? – UpLevelRewards

How to Claim Your $750 Shein Gift Card Is It Legit or Fake? – UpLevelRewards

Tempe, Arizona, May 03, 2025 (GLOBE NEWSWIRE) -- You might have heard about the Shein $750 gift card thing on…

18 hours ago
Herz P1 Smart Ring Under Review: Can Vital Health Smart Ring Really Track Your Health? Best Smart RingHerz P1 Smart Ring Under Review: Can Vital Health Smart Ring Really Track Your Health? Best Smart Ring

Herz P1 Smart Ring Under Review: Can Vital Health Smart Ring Really Track Your Health? Best Smart Ring

Akron, Ohio, May 03, 2025 (GLOBE NEWSWIRE) -- Ever since the years of the pandemic have passed by, there is…

18 hours ago
ETH is about to skyrocket? SIX MINING helps you earn passive income every dayETH is about to skyrocket? SIX MINING helps you earn passive income every day

ETH is about to skyrocket? SIX MINING helps you earn passive income every day

london, united kingdom, May 02, 2025 (GLOBE NEWSWIRE) -- BlackRock, the world's largest asset management company, purchased $67.5 million worth…

18 hours ago
District Court Dismisses Dispute Filed by United Therapeutics Against LiquidiaDistrict Court Dismisses Dispute Filed by United Therapeutics Against Liquidia

District Court Dismisses Dispute Filed by United Therapeutics Against Liquidia

Court will not hear cross-claim that challenges the PH-ILD indication in the tentatively approved NDA for YUTREPIAFDA can grant final…

18 hours ago